CMFRI, Library (2022) CMFRI signs MoU to launch product from seaweeds to combat fatty liver disease News Drum dated 20th December 2022. News Drum.
![[img]](https://eprints.cmfri.org.in/style/images/fileicons/text.png) |
Text
News Drum_20-12-2022.pdf Download (38kB) |
Official URL: https://www.newsdrum.in/national/cmfri-signs-mou-t...
Abstract
CMFRI has signed an MoU with a private company dealing with health products for commercial production and marketing Cadalmin LivCure extract. A unique blend of 100% natural bioactive ingredients extracted from select seaweeds, the product is made using eco-friendly technology to improve liver health. It is the ninth nutraceutical developed by the CMFRI.
| Item Type: | Article |
|---|---|
| Subjects: | CMFRI News Clippings |
| Divisions: | CMFRI-Kochi > Marine Biotechnology, Fish Nutrition and Health Division Subject Area > CMFRI > CMFRI-Kochi > Marine Biotechnology, Fish Nutrition and Health Division CMFRI-Kochi > Marine Biotechnology, Fish Nutrition and Health Division Subject Area > CMFRI-Kochi > Marine Biotechnology, Fish Nutrition and Health Division |
| Depositing User: | Mr. Augustine Sipson N A |
| Date Deposited: | 28 Dec 2022 07:12 |
| Last Modified: | 28 Dec 2022 07:12 |
| URI: | http://eprints.cmfri.org.in/id/eprint/16561 |
Actions (login required)
 |
View Item |
